Format

Send to

Choose Destination
Ther Adv Musculoskelet Dis. 2014 Oct;6(5):185-202. doi: 10.1177/1759720X14546350.

Medication-induced osteoporosis: screening and treatment strategies.

Author information

1
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
2
Department of Medicine, University of Oklahoma Health Sciences Center, and Veterans Affairs Medical Center, 975 NE 10th St, BRC209, Oklahoma City, OK 73104, USA.

Abstract

Drug-induced osteoporosis is a significant health problem and many physicians are unaware that many commonly prescribed medications contribute to significant bone loss and fractures. In addition to glucocorticoids, proton pump inhibitors, selective serotonin receptor inhibitors, thiazolidinediones, anticonvulsants, medroxyprogesterone acetate, aromatase inhibitors, androgen deprivation therapy, heparin, calcineurin inhibitors, and some chemotherapies have deleterious effects on bone health. Furthermore, many patients are treated with combinations of these medications, possibly compounding the harmful effects of these drugs. Increasing physician awareness of these side effects will allow for monitoring of bone health and therapeutic interventions to prevent or treat drug-induced osteoporosis.

KEYWORDS:

anticonvulsants; aromatase; calcineurin; glucocorticoids; medroxyprogesterone; osteoporosis; proton pump; serotonin; thiazolidinediones

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center